{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:10Z","timestamp":1788782890460,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tmrv.2026.151009","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T01:01:49Z","timestamp":1781312509000},"page":"151009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Safety of Tranexamic Acid in Cancer Surgery: Clinical Evidence and Biological Rationale"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-9123","authenticated-orcid":false,"given":"Victoria","family":"Ivankovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardin","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"McIsaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-2601","authenticated-orcid":false,"given":"Guillaume","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9734","key":"10.1016\/j.tmrv.2026.151009_bib0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Olldashi","year":"2010","journal-title":"Lancet"},{"issue":"10084","key":"10.1016\/j.tmrv.2026.151009_bib0002","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.tmrv.2026.151009_bib0003","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMx180005","article-title":"Tranexamic acid in patients undergoing coronary-artery surgery","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.tmrv.2026.151009_bib0004","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2026.151009_bib0005","unstructured":"Tranexamic Acid - StatPearls - NCBI Bookshelf [Internet]. Accesssed November 24, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532909\/?utm_source=chatgpt.com"},{"key":"10.1016\/j.tmrv.2026.151009_bib0006","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2147\/JMDH.S337250","article-title":"Efficacy and safety of tranexamic acid in cancer surgery. An update of clinical findings and ongoing research","volume":"15","author":"Zec","year":"2022","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.tmrv.2026.151009_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-025-06185-y","article-title":"Repurposing tranexamic acid as an anticancer drug: a systematic review and meta-analysis","author":"Kristjansen","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"10.1016\/j.tmrv.2026.151009_bib0008","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jama.2024.11783","article-title":"Tranexamic acid in patients undergoing liver resection: the HeLiX randomized clinical trial","volume":"332","author":"Karanicolas","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077012","article-title":"Perioperative treatment with tranexamic acid in melanoma (PRIME): protocol for a Danish multicentre randomised controlled trial investigating the prognostic and treatment-related impact of the plasminogen-plasmin pathway","volume":"14","author":"Kristjansen","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.tmrv.2026.151009_bib0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.21037\/hbsn-2025-502","article-title":"The value of tranexamic acid in liver resection should not be exaggerated or ignored","volume":"14","author":"Ge","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.tmrv.2026.151009_bib0011","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamasurg.2024.4183","article-title":"Tranexamic acid during radical cystectomy a randomized clinical trial","volume":"12","author":"Breau","year":"2024","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0012","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1601-0825.2008.01507.x","article-title":"Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro","volume":"15","author":"Suojanen","year":"2009","journal-title":"Oral Dis"},{"issue":"SUPPL. 1","key":"10.1016\/j.tmrv.2026.151009_bib0013","article-title":"Effect of lysine antifibrinolytics and cyclooxygenase inhibitors on the proteolytic profile of breast cancer cells interacting with macrophages or endothelial cells","volume":"113","author":"Afsharimani","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tmrv.2026.151009_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.792600","article-title":"Repurposing tranexamic acid as an anticancer agent","volume":"12","author":"Law","year":"2022","journal-title":"Front Pharmacol"},{"issue":"7_Supplement","key":"10.1016\/j.tmrv.2026.151009_bib0015","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2023-4879","article-title":"Abstract 4879: Inhibition of amino acid transporters as a novel mechanism of action of the repurposed anti-cancer agent tranexamic acid","volume":"83","author":"Law","year":"2023","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.tmrv.2026.151009_bib0016","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.7150\/jca.68169","article-title":"Tranexamic acid reduces endometrial cancer effects through the production of angiostatin","volume":"13","author":"Hiramoto","year":"2022","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0017","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/php.13025","article-title":"Tranexamic acid ameliorates nonmelanoma skin cancer induced by long-term ultraviolet a irradiation","volume":"95","author":"Hiramoto","year":"2019","journal-title":"Photochem Photobiol"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151009_bib0018","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/bjc.1982.220","article-title":"Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma tranexamic acid (trans-4-aminomethyl cyclohexane-1-carboxylic acid) (t-AMCHA) and urokinase Uronase, Mochida","volume":"46","author":"Tanaka","year":"1982","journal-title":"Br J Cancer"},{"issue":"4549","key":"10.1016\/j.tmrv.2026.151009_bib0019","first-page":"1020","article-title":"Interference with dimethylhydrazine induction of colon tumors in mice by \u03f5-aminocaproic acid","volume":"216","author":"Corasanti","year":"1982","journal-title":"Source: Science, New Series"},{"key":"10.1016\/j.tmrv.2026.151009_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-6-56","article-title":"The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis","volume":"6","author":"Perides","year":"2006","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.tmrv.2026.151009_bib0021","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/33.5.753","article-title":"Effect of inhibitors of fibrinolytic enzymes on development of pulmonary metastases","volume":"33","author":"Cliffton","year":"1964","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.tmrv.2026.151009_bib0022","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/apm.1966.68.3.347","article-title":"Effect of heparin and plasminogen inhibitor (EACA) in brief and prolonged treatment on intravenously injected tumour cells","volume":"68","author":"Boeryd","year":"1966","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"3","key":"10.1016\/j.tmrv.2026.151009_bib0023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/apm.1965.65.3.395","article-title":"Action of heparin and plasminogen inhibitor (EACA) on metastatic tumour spread in an isologous system","volume":"65","author":"Boeryd","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10585-008-9221-z","article-title":"Effect of anti-fibrinolytic therapy on experimental melanoma metastasis","volume":"26","author":"Kirstein","year":"2009","journal-title":"Clin Exp Metastasis"},{"issue":"7829","key":"10.1016\/j.tmrv.2026.151009_bib0025","article-title":"Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial","volume":"343","author":"Crescenti","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2026.151009_bib0026","first-page":"335","article-title":"Single-Dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind","author":"Lundin","year":"2014","journal-title":"placebo-controlled randomized multicenter study"},{"issue":"4","key":"10.1016\/j.tmrv.2026.151009_bib0027","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/joacp.JOACP_122_17","article-title":"Single intravenous bolus versus perioperative continuous infusion of tranexamic acid to reduce blood loss in abdominal oncosurgical procedures: a prospective randomized double-blind clinical study","volume":"34","author":"Prasad","year":"2018","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.tmrv.2026.151009_bib0028","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.20190","article-title":"Effect of two different tranexamic acid doses on blood loss in head and neck cancer surgery: a randomized, double-blind, controlled study","author":"Babu","year":"2021","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.tmrv.2026.151009_bib54","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/aogs.14567","article-title":"Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: a randomized controlled clinical trial","volume":"102","author":"Yang","year":"2023","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.tmrv.2026.151009_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2106\/JBJS.24.00261","article-title":"Intraoperative tranexamic acid infusion reduces perioperative blood loss in pediatric limb-salvage surgeries: a double-blinded randomized placebo-controlled trial","volume":"107","author":"El Ghoneimy","year":"2025","journal-title":"J. Bone Joint Surg. Am. Vol."},{"key":"10.1016\/j.tmrv.2026.151009_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/crst.crst_228_24","article-title":"The effects of preoperative intravenous tranexamic acid on intraoperative blood loss in cancer surgeries at a tertiary care center in South India: a double-blind randomized controlled trial","volume":"8","author":"Shunmugam","year":"2025","journal-title":"Cancer Res. Stat. Treat."},{"key":"10.1016\/j.tmrv.2026.151009_bib0029","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.10105","article-title":"The effectiveness of tranexamic acid in patients with proximal femoral tumor resection prosthesis","author":"Atalay","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.tmrv.2026.151009_bib0030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/TCRM.S516261","article-title":"Tranexamic acid demonstrated a trend toward decreased perioperative blood loss in posterior decompression surgery of patient with metastatic spinal tumor","volume":"21","author":"Cui","year":"2025","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"10.1016\/j.tmrv.2026.151009_bib0031","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jso.27391","article-title":"Intravenous tranexamic acid is associated with an increased risk of pulmonary embolism following sarcoma resection","volume":"128","author":"Foster","year":"2023","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.tmrv.2026.151009_bib0032","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jso.26448","article-title":"Tranexamic acid in patients with current or former cancer undergoing hip and knee arthroplasty","volume":"123","author":"Varady","year":"2021","journal-title":"J Surg Oncol"},{"issue":"4_suppl","key":"10.1016\/j.tmrv.2026.151009_bib0033","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.2024.42.4_suppl.641","article-title":"Safety of intraoperative tranexamic acid use on the risk of venous thromboem-bolism (VTE) in patients undergoing robotic assisted radical cystectomy (RARC)","volume":"42","author":"Ahmed","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.tmrv.2026.151009_bib0034","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/JU.0000000000004358","article-title":"Intraoperative tranexamic acid in radical cystectomy: impact on bleeding, thromboembolism, and survival outcomes","volume":"213","author":"Ahmed","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.tmrv.2026.151009_bib0035","first-page":"84","article-title":"Tranexamic acid use is not associated with the risk of melanoma in Danish women: a nested case-control study using Danish health registries","author":"B\u00f8nnelykke-Behrndtz","year":"2023","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"10.1016\/j.tmrv.2026.151009_bib49","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/01.brs.0000209304.76581.c5","article-title":"Tranexamic acid for hemostasis in the surgical treatment of metastatic tumors of the spine","volume":"31","author":"Bednar","year":"2006","journal-title":"Spine"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1213\/XAA.0000000000001129","article-title":"Incidence of thromboembolic events in oncology patients receiving intraoperative tranexamic acid during orthopedic surgery: a retrospective review at a comprehensive cancer center","volume":"14","author":"Ackerman","year":"2020","journal-title":"A&A Practice"},{"key":"10.1016\/j.tmrv.2026.151009_bib50","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.hpb.2024.12.021","article-title":"Risk factors associated with venous thromboembolism after hepatectomy in oncology patients","volume":"27","author":"Greenberg","year":"2025","journal-title":"HPB"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0036","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(76)90334-4","article-title":"Effect of apotinin, EACA and heparin on growth and vasopeptide system of murphy-sturm lymphosarcoma *, **","volume":"38","author":"Back","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.tmrv.2026.151009_bib0037","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0090-8258(86)90026-0","article-title":"The inhibitory effect of tranexamic acid on human ovarian carcinoma cell grown in vitro and in vivo","volume":"24","author":"Kikuchi","year":"1986","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.tmrv.2026.151009_bib0038","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00016348609157383","article-title":"Adjuvant effects of tranexamic acid to chemotherapy in ovarian cancer patients with large amount of ascites","volume":"65","author":"Kikuchi","year":"1986","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tmrv.2026.151009_bib0039","article-title":"Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation1","author":"Kikuchi","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.tmrv.2026.151009_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CGM.S32797","article-title":"Impact of Transfusion on Cancer Growth and Outcome","volume":"9","author":"Goubran","year":"2016","journal-title":"Cancer Growth Metastasis"},{"key":"10.1016\/j.tmrv.2026.151009_bib0041","doi-asserted-by":"crossref","DOI":"10.1159\/000525706","article-title":"Immunomodulatory properties of packed red blood cells during storage","author":"Laur\u00e9n","year":"2023","journal-title":"Transf Med Hemother"},{"key":"10.1016\/j.tmrv.2026.151009_bib0042","doi-asserted-by":"crossref","DOI":"10.1097\/MOH.0000000000000376","article-title":"Transfusion-related immunomodulation: a reappraisal","author":"Youssef","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tmrv.2026.151009_bib0043","doi-asserted-by":"crossref","DOI":"10.1111\/trf.14488","article-title":"Mechanisms of red blood cell transfusion-related immunomodulation","author":"Remy","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2026.151009_bib0044","doi-asserted-by":"crossref","unstructured":"Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB Blood transfusion and cancer surgery outcomes: a continued reason for concern. Surgery (United States). 2012. doi:10.1016\/j.surg.2012.06.008","DOI":"10.1016\/j.jss.2011.11.481"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/ija.ija_576_22","article-title":"Evaluation of efficacy and safety of a single dose Tranexamic acid in reducing blood loss during colorectal cancer surgery. A randomised, placebo controlled, double-blinded study","volume":"67","author":"Shaker","year":"2023","journal-title":"Indian J Anaesth"},{"issue":"2","key":"10.1016\/j.tmrv.2026.151009_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2025.5498","article-title":"Perioperative use of tranexamic acid in general surgery: a systematic review and meta-analysis","volume":"161","author":"Delgado","year":"2026","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.tmrv.2026.151009_bib0047","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/jso.26142","article-title":"Preoperative tranexamic acid does not reduce transfusion rates in major oncologic surgery: Results of a randomized, double-blind, and placebo-controlled trial","volume":"122","author":"Wright","year":"2020","journal-title":"J Surg Oncol"},{"issue":"Supplement 2","key":"10.1016\/j.tmrv.2026.151009_bib0048","doi-asserted-by":"crossref","first-page":"LBA","DOI":"10.1182\/blood-2025-LBA-5","article-title":"A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: the traction trial","volume":"146","author":"Houston","year":"2025","journal-title":"Blood"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796326000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796326000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:28Z","timestamp":1788779848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796326000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0887796326000507"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2026.151009","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Safety of Tranexamic Acid in Cancer Surgery: Clinical Evidence and Biological Rationale","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2026.151009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151009"}}